Tempus completed their IPO on June 14, 2024 to list on NASDAQ with ticker TEM. They raised $410.7MM at an implied valuation of $6.1B. Forge no longer actively tracks this company.
Tempus was founded in 2015 by Eric Lefkofsky. Tempus has not officially endorsed a plan to participate in an IPO.
Tempus is an artificial intelligence company that specializes in healthcare advancement. Per Forge data, Tempus raised $1.3 billion in funding over 13 rounds. Their latest funding was raised on Oct 20, 2022. Key investors include Revolution, Google, and New Enterprise Associates.
These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
You may invest in Tempus as it is a public company listed on the NASDAQ with ticker TEM. But if you are an accredited investor interested in buying pre-IPO shares of a private company, you can learn more about how to invest in the private market or register today to get started.
Can you sell shares of Tempus before it goes public?
You can no longer sell shares of Tempus on Forge as this company is no longer private. However, if you own shares of a private company, Forge may be able to help you sell them in a way that works for you and the company. Learn more or register with us today to get started.
What is the pre-IPO value of my Tempus shares?
Forge can no longer determine the value of Tempus shares as this company is no longer private. However, if you own shares of a private company, Forge may help you value and sell them in a way that works for you and the company. Learn more or register with us today to get started.
Is Tempus a publicly traded company?
Tempus became a public company following its IPO on 06/14/2024 and is now traded on the NASDAQ under the ticker TEM.
To learn more about Tempus potential IPO
Will Tempus go IPO?
Tempus became a public company following its IPO on 06/14/2024 and is now traded on the NASDAQ under the ticker TEM.
What is Tempus’ IPO price?
The IPO price of Tempus is not currently available.
When was Tempus founded?
Tempus was founded in 2015.
What is Tempus funding to date?
Tempus has raised $3.06B to date.
Tempus major investors
Alphabet
Ares Management
Franklin Templeton Investments
Franklin Venture Partners
Kilmahew Ventures
Lightbank
New Enterprise Associates
Novo Holdings
Revolution
Show All InvestorsShow Fewer Investors
Tempus pre-IPO valuation and funding rounds
Funding history chart
Funding round and deals details
Funding Date
Round
Amount Raised
Price per Share
Post-Money Valuation 3
Key Investors
04/30/2024
Series G-5
$200MM
$57.31
$8.89B
Softbank
Price per Share
$ xx.xx
Shares Outstanding
3,489,981
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.3%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Softbank
10/11/2023
Series G-4
$45.61MM
$57.31
$8.7B
Scottish Mortgage Investment Trust
Price per Share
$ xx.xx
Shares Outstanding
795,911
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.3%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Scottish Mortgage Investment Trust
10/03/2022
Series G-3
$99.05MM
$57.31
$8.45B
Blue Media, Scottish Mortgage Investment Trust, The Schiehallion Fund
Price per Share
$ xx.xx
Shares Outstanding
1,728,360
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
4.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Blue Media, Scottish Mortgage Investment Trust, The Schiehallion Fund
01/15/2021
Series G-2
$197.89MM
$57.31
$8.12B
Baillie Gifford, Blue Media, Franklin Templeton, Google, Novo Holdings, Scottish Mortgage Investment Trust, The Schiehallion Fund, T. Rowe Price
Price per Share
$ xx.xx
Shares Outstanding
3,453,139
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Baillie Gifford, Blue Media, Franklin Templeton, Google, Novo Holdings, Scottish Mortgage Investment Trust, The Schiehallion Fund, T. Rowe Price
03/13/2020
Series G
$97.31MM
$38.35
$5B
Baillie Gifford, Franklin Templeton Investments, New Enterprise Associates, Novo Holdings
Price per Share
$ xx.xx
Shares Outstanding
2,537,290
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Baillie Gifford, Franklin Templeton Investments, New Enterprise Associates, Novo Holdings
05/30/2019
Series F
$200MM
$24.76
$3.1B
Baillie Gifford, Franklin Templeton Investments, New Enterprise Associates, Novo Holdings, Revolution Group, T.Rowe Price
Price per Share
$ xx.xx
Shares Outstanding
8,077,674
Liquidation Pref Order
6
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Baillie Gifford, Franklin Templeton Investments, New Enterprise Associates, Novo Holdings, Revolution Group, T.Rowe Price
08/23/2018
Series E
$111.02MM
$16.74
$2B
Baillie Gifford, New Enterprise Associates, Revolution, T. Rowe Price
Price per Share
$ xx.xx
Shares Outstanding
6,630,905
Liquidation Pref Order
7
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Baillie Gifford, New Enterprise Associates, Revolution, T. Rowe Price
03/30/2018
Series D
$80MM
$9.37
$1.03B
Kinship Trust Company, New Enterprise Associates, Revolution, T.Rowe Price
Price per Share
$ xx.xx
Shares Outstanding
8,534,330
Liquidation Pref Order
8
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Kinship Trust Company, New Enterprise Associates, Revolution, T.Rowe Price
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced publication of its study, "Actionable structural variant detection via RNA-NGS and DNA-NGS in patients with advanced non-small cell lung cancer," in JAMA Network Open. Tempus recently conducted a retrospective study of more than 5,500 patients with advanced non-small cell lung cancer (NSCLC) and found that concurrent RNA- and DNA-based next-generation sequencing (NGS) led to the detection of more actionable structural variants compared to DNA sequencing alone.
Tempus AI, backed by Japanese tech investment firm SoftBank Group (9984.T), opens new tab, is targeting a valuation of up to $6.10 billion for its U.S. initial public offering, nearly three years after the genetics-testing company laid the ground for its listing. The listing of the company, which is led by e-commerce marketplace Groupon (GRPN.O), opens new tab co-founder Eric Lefkofsky and is yet to be profitable, will test investor appetite.
Tempus AI Inc., a technology platform company using artificial intelligence to process medical data, filed for an initial public offering, joining a rush of companies going public while touting their AI credentials. The company said in its filing Monday with the US Securities and Exchange Commission that it’s creating “intelligent diagnostics” for precision medicine. Tempus AI didn’t give details of the IPO such as the offer price, which will be included in future filings.
Tempus, a biotechnology research company providing physicians with AI-enabled medicine solutions, is collaborating with SkylineDx to make their Merlin Test more accessible to melanoma cancer patients in the U.S. The test assesses the metastasis risk on a patient’s sentinel lymph nodes based on genes from the main tumor, tumor thickness, and the patient’s age. The collaboration between Tempus and SkylineDx will give healthcare providers better insights into early-stage treatment options depending on each patient’s need.
Track trading activity and investor momentum across thousands of private companies. Register to view last matched prices and additional transactional details.
Forge, your trusted partner for pre-IPO insights and Tempus data
Forge is the trusted platform for buying and selling pre-IPO shares. Investors and shareholders worldwide rely on our deep data insights, liquidity solutions, and tailored investment opportunities to navigate the private market. Register to get started.
PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES
Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions on Forge.
Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
Actively traded companies are companies with a high market activity with the highest post-money valuation in the same sector.
‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.
The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.
Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.
PRIVATE MARKET UPDATE
